Tucson / Philadelphia / Salvador / Toronto / Lancaster / London / /
Company
Fox Chase / Norton / Title Prospective Ovarian Cancer Data Bank / /
Continent
Europe / /
Country
Iceland / Canada / Australia / United Kingdom / / /
Facility
Fox Chase Center / University of Utah / University Health Network / Georgetown University / University of Texas Health Science Center / Montreal General Hospital Research Institute / Memorial Sloan-Kettering Cancer Center / BRCA complex / University of Arizona / University of California / Memorial SloanKettering Cancer Center / University of Texas MD Anderson Cancer Center / University of Texas Southwestern Medical Center / Mayo Clinic / Fox Chase Cancer Center / Duke University Medical Center / McGill University / /
IndustryTerm
preventive services / mutation carrier / experimental tools / carrier breast cancer risk modifier locus / ataxia telangiectasia gene product / /
MedicalCondition
varied cancer / ovarian cancer / Title ATM Deficiency / primary breast cancer / BRCA1/BRCA2-associated breast cancer / disabled tumor / contralateral breast cancer / BRCA-mutated breast cancers / epithelial ovarian cancer / breast cancer / brain tumors / ovarian leiomyosarcomas / invasive serous and mucinous ovarian cancers / tumor / familial breast cancers / subsequent breast cancer / familial pancreatic cancer / cancer / tumors / gynecologic cancers / non-mucinous ovarian cancer / BRCA-associated breast carcinoma / novel BRCA1 carrier breast cancer / Male Breast Cancer / childhood cancer / breast and ovarian cancer / diseases / medulloblastoma / male and female breast cancer / depression / early-onset breast cancer / ataxia telangiectasia / Fanconi anemia / increased ovarian cancer / familial and hereditary factors / hereditary ovarian cancer / BRCA2-mutated cancers / putative serous cancer / BRCA2 dysfunction / high-grade leiomyosarcomas / serous carcinoma / invasive non-mucinous ovarian cancer / human ovarian tumors / lowpenetrance breast cancer / breast and gynecologic cancer / Fanconi anemia J / breast cancers / ataxia-telangiectasia / disease / novel ovarian cancer / ATM deficiency / early-onset familial breast cancer / sporadic cancers / tumour / ataxia telangiectasia gene product / clear cell ovarian cancer / sarcomas / hereditary breast-ovarian cancer / /
BRCA1linked / McGill University / University of Texas Southwestern Medical Center at Dallas / Institute for Cancer Research / University of Utah / Montreal General Hospital Research Institute / Georgetown University / University of Texas Health Science Center at San Antonio / University of Texas / DoD BCRP / Icelandic Cancer Society / Memorial SloanKettering Cancer Center / University of California / Davis / Memorial Sloan-Kettering Cancer Center / Department of Defense / University of Arizona / Duke University Medical Center / /
Person
Nazneen Rahman / Mark Robson / Mark Skolnick / Patricia Shaw / Wolf Heyer / Nicholas Ting / Kenneth Offit / Lei Zheng / Noah Kauff / David Livingston / Steven Narod / Hope Scholar / Wen-Hwa Lee / Mary Daly / Denise Connolly / Stephen Elledge / Donato Romagnolo / Bing Xia / Jorunn Eyfjord / Gail Tomlinson / Ann Oncol / Junjie Chen / Jacques Simard / Mary-Claire King / David Bowtell / Maria Jasin / Andrew Berchuck / William Foulkes / David Goldgar / Paul Engstrom / Gillian Mitchell / Hope Plenary / Irene Ward / Stephen Kowalczykowski / Susan Neuhausen / Fergus Couch / Henry Lynch / published describing Dr. Kowalczykowski / /
BRCA Timeline: DoD Breast Cancer Research Program (BCRP) and Ovarian Cancer Research Program (OCRP) Research Contributions BRCA gene mutations have been linked to increased breast and/or ovarian cancer risk. The Departme